Lok Sabha Question No. 786 (UNSTARRED), answered on 2021-07-23
Subject: Price of Vaccines
Ministry: HEALTH AND FAMILY WELFARE
Asked by: P. Velusamy, K. Shanmuga Sundaram, Locket Chatterjee, T. R. Paarivendhar, A. Ganeshamurthi

## GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE

LOK SABHA UNSTARRED QUESTION NO. 786 TO BE ANSWERED ON 23 RD JULY, 2021

## PRICE OF VACCINES

## 786. SHRI VELUSAMY P.:

SHRI SHANMUGA SUNDAR AM K.:

MS. LOCKET CHATTERJEE:

DR. T.R.PAARIVENDHAR :

SHRI A. GANESHAMURTH I:

Will the Minister of HEALTH AND FAMILY WE LFARE be pleased to state:

- (a)  the  fund  allocated  to  provide  free  COVID vaccination  to  all  the  citizens  along  with  the method devised to implement the scheme throughout the country;
- (b) the details of Public and Private manufacturers/ companies permitted by the Government to produce and supply COVID vaccination along with the terms and conditions laid down in this regard;
- (c) the number of vaccine doses made available by these manufacturers/companies in the country as ondate along with the estimated cost and methodology adopted to fix the rate/price of these vaccinations;
- (d) whether the costing of the vaccine includes the cost of cold chain infrastructure an d trained personnel required for mass vaccination, if so, the details thereof;
- (e) whether result/data of 3rd phase trials of these vaccines are available with the Government, if so, the details thereof; and
- (f) whether the Government is having any proposal t  import anti - COVID vaccines from foreign countries, if so, the details thereof?

## ANSWER

## THE MINISTER OF STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE (DR . BHARATI PRAVIN PAW AR )

- (a): INR 35,000  crore has  been  budgeted  for  implementation  of  COVID - 19  Vaccination Programme in the FY 2021- 22.

(b) : As  per  the  provisions  of  New  Drugs  and  Clinical  Trials  Rules,  2019  under  Drugs  a Cosmetics Act, 1940, the national regulator i.e. CDSCO has granted permissio ns for restricted use  in  emergency  situation  to  the  M/s  Serum  Institute  of  India  for  Covishield  vaccin BharatBiotech Int ernational Limited for Covaxin and Dr. Reddy's Laboratories Ltd for Sputnik V.

(c): As on 20 thJuly 2021, a total of 42.52 crore doses of Covishield and Covaxin have been supplied for COVID - 19  vaccination drive in India. Till July 2021, around INR 8071.09 crore have been spent on purchase of COVID - 19 vaccines .

The price of vaccine for procurement by Government of India is negotiate d by National Expert  Group  on  Vaccine  Administration  for  COVID - 19  (NEGVAC)  and  its  subgroups involving detailed deliberations with the vaccine manufacturers.

(d): The cost of vaccine includes delivery of vaccine in a temperature controlled enviro the consignee points communicated by Government of India to the manufacturer.

(e): Yes, the interim data of Phase -III of Covaxin and of Phase -II/III of Covishield and Sputnik V have been submitted by the respective manufacturers to the national regulator i .e. CDSCO.

(f): Permissions for import and restricted use in emergency situation have also been given Dr.  Reddy's  Laboratories  Ltd  for  Sputnik  V  and    M/s  Cipla  Limited  for  Moderna's  mRNA vaccine.